BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/30/2016 5:39:00 PM | Browse: 1480 | Download: 2969
Publication Name World Journal of Gastroenterology
Manuscript ID 20893
Country Iran
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Randomized Controlled Trial
Article Title Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial
Manuscript Source Unsolicited Manuscript
All Author List Fariborz Mansour-Ghanaei, Farahnaz Joukar, Zahra Taherzadeh, Homayoon Sokhanvar and Tolou Hasandokht
Funding Agency and Grant Number
Corresponding Author Fariborz Mansour-Ghanaei, MD, AGAF, Professor of Gastroenterology, Gastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences, Razi Hospital, Sardar-Jangle Ave., P.O., Rasht 41448-95655, Iran. ghanaei@gums.ac.ir
Key Words Naproxen; Nonsteroidal anti-inflammatory drugs; Pancreatic duct injection; Post-endoscopic retrograde cholangiopancreatography; Pancreatitis; Serum amylase
Core Tip Acute pancreatitis is the most common serious complication of endoscopic retrograde cholan-giopancreatography (ERCP); prevention of post-ERCP pancreatitis (PEP) has become more challenging. The use of nonsteroidal anti-inflammatory drugs is effective in this condition. This study evaluated the efficacy of rectally administered naproxen for the prevention of PEP in composition with placebo immediately before ERCP.
Publish Date 2016-05-30 17:40
Citation Mansour-Ghanaei F, Joukar F, Taherzadeh Z, Sokhanvar H, Hasandokht T. Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial. World J Gastroenterol 2016; 22(21): 5114-5121
URL http://www.wjgnet.com/1007-9327/full/v22/i21/5114.htm
DOI http://dx.doi.org/10.3748/wjg.v22.i21.5114
Full Article (PDF) WJG-22-5114.pdf
Full Article (Word) WJG-22-5114.doc